TY  - JOUR

T1  - Not cost-effective at zero price : valuing and paying for combination therapies in cancer

JO  - Expert Review of Pharmacoeconomics & Outcomes Research

PY  - 2021/01/21

AU  - Latimer NR

AU  - Towse A

AU  - Henshall C

ED  - 

DO  - DOI: 10.1080/14737167.2021.1879644

PB  - Taylor & Francis

VL  - 21

IS  - 3

SP  - 331

EP  - 333

Y2  - 2025/10/31

ER  -